A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool

Nov-19

Database Gastroenterology Musculoskeletal Pharmacoepidemiology

AUTHORS : Dr Rachel E. Sobel, Epidemiology/Worldwide Research and Development, Pfizer Inc, 235 East 42nd St. MS# 219-9-1, New York, NY, 10017, USA – Email: rachel.sobel@pfizer.com

JOURNAL : Drug Safety

REFERENCE: 42(11):1365-1376

DOI : 10.1007/s40264-019-00853-y

Read more